Is West Pharmaceutical Services, Inc. overvalued?

West Pharmaceutical Services, Inc. (WST) looks overvalued — trading about 59% above its fair value.

Overvalued

Price

$416.42

Fair value

$171.30

Current P/E

52.2

Normal P/E

21.5

Market cap

$29.01B

Dividend yield

0.2%

Return on equity

21.1%

Sector

Healthcare

Fair value compares WST's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks